PIK3CA
PIK3CA Uses, Dosage, Side Effects, Food Interaction and all others data.
PIK3CA is under investigation in clinical trial NCT02957266 (Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy).
| Trade Name | PIK3CA |
| Generic | PIK3CA |
| PIK3CA Other Names | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, PIK3CA |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PIK3CA
